Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity

19 Sept 2012

Abstract excerpt

Drug/radiation resistance to treatment and tumor relapse are major obstacles in identifying a cure for cancer. Development of novel agents that address these challenges would therefore be of the upmost importance in the fight against cancer. In this regard, studies show that the antiapoptotic protein survivin is a central molecule involved in both hurdles. Using cancer cell-based survivin-reporter systems (US...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related Molecular Pathways
Share to Cancer therapeutics and mechanisms
Share to Cell death mechanisms and regulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23029106
DOI: 10.1371/journal.pone.0045571

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor ActivityPMID 23029106Read ↗

Structure–Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor ActivitySemantic proximity Read ↗

FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistanceSemantic proximity Read ↗

Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancersSemantic proximity Read ↗

Survivin Small Molecules Inhibitors: Recent Advances and ChallengesSemantic proximity Read ↗

FL118 Induces p53-Dependent Senescence in Colorectal Cancer Cells by Promoting Degradation of MdmXSemantic proximity Read ↗

TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity.Semantic proximity Read ↗

Leveraging Synergy: The Therapeutic Potential of SN-38 and Immunotherapy in Breast and Prostate Cancer TreatmentSemantic proximity Read ↗

Recent Advances on Small-Molecule Survivin InhibitorsSemantic proximity Read ↗

The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis InhibitionSemantic proximity Read ↗

A cell type-selective apoptosis-inducing small molecule for the treatment of brain cancerSemantic proximity Read ↗

BindingDB Entry 2025: Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.Semantic proximity Read ↗

Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.